Beximco Pharmaceuticals PLC. (DSE:BXPHARMA)
Bangladesh · Delayed Price · Currency is BDT 113.30
+0.60 (0.53%)
At close: Jan 22, 2026
DSE:BXPHARMA Market Cap
DSE:BXPHARMA has a market cap or net worth of 50.54 billion as of January 23, 2026. Its market cap has increased by 33.29% in one year.
Market Cap
50.54B
Enterprise Value
57.84B
Revenue
46.34B
Ranking
n/a
PE Ratio
7.96
Stock Price
113.30
Market Cap Chart
Since January 3, 2000, DSE:BXPHARMA's market cap has increased from 1.91B to 50.54B, an increase of 2,545.05%. That is a compound annual growth rate of 13.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 50.54B | 10.97% |
| Dec 30, 2025 | 45.55B | 25.12% |
| Dec 30, 2024 | 36.40B | -44.19% |
| Dec 28, 2023 | 65.22B | - |
| Dec 29, 2022 | 65.22B | -24.13% |
| Dec 30, 2021 | 85.97B | 1.15% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Square Pharmaceuticals PLC. | 190.76B |
| Renata | 46.17B |
| Unilever Consumer Care | 42.00B |
| Beacon Pharmaceuticals | 24.62B |
| The ACME Laboratories | 15.62B |
| The IBN SINA Pharmaceutical Industry | 10.13B |
| Asiatic Laboratories | 6.66B |
| Orion Pharma | 6.51B |